Scienture Holdings, Inc. announced a securities purchase agreement with institutional investors for 3,225,000 shares of common stock.
The offering price is $1.20 per share, with expected gross proceeds of approximately $3.9 million.
The registered direct offering is set to close on August 15, 2025, subject to customary closing conditions.
Offering Details
3,225,000 shares of common stock to be purchased at $1.20 per share.
Gross Proceeds
Expected gross proceeds of approximately $3.9 million before deduction of fees.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
- The offering is part of Scienture's strategy to raise funds for future endeavors.
- The effective shelf registration statement allows for a direct offering to institutional investors.
The securities purchase agreement marks a significant milestone for Scienture Holdings, Inc., enabling the company to advance its pharmaceutical operations.